iHEART-SA Intervention Study (iHEART-SA)

May 3, 2023 updated by: Professor Francois Venter, University of Witwatersrand, South Africa

The Integrating HIV and hEART Health in South Africa Intervention Study

Using qualitative data during the formative phase the IHEART-SA research study filled deficiencies in knowledge regarding: 1) what barriers exist to integrating hypertension care within the HIV care setting in South Africa and, 2) how a hypertension care intervention can be adapted to effectively and sustainably function in this care setting. These data have been used to design a context-relevant intervention package for implementation in the next phase of effectiveness-implementation testing, answering the research question: How does an intervention aimed at enhancing hypertension diagnosis and management in people living with HIV improve the delivery of guideline-recommended care in primary healthcare clinics in Gauteng, South Africa, and hypertension control among patients?

The study will use an effectiveness-implementation study design. This design allows for the testing of strategies to promote integration of proven interventions in real-world practice (i.e., implementation strategies), while simultaneously assessing clinical effectiveness (i.e., patient level outcomes). For this the study will use a randomized cluster stepped-wedge study design where nine clinics (grouped in clusters of three) will be assigned to a time at which they initiate the intervention.

Study Overview

Status

Recruiting

Conditions

Detailed Description

Investigational interventions:

Implementation facilitation of improved hypertension screening and management in the HIV care setting through the iHEART-SA intervention model comprising:

  1. Information management system
  2. Task shifting
  3. Audit and feedback
  4. Healthcare worker education and training
  5. Patient education and support

Study design:

Cluster randomized stepped wedge effectiveness-implementation type 2 hybrid

Study objectives:

  1. Assess the short- and long-term effects of an implementation strategy (i.e., healthcare worker intervention) on the adoption and implementation of hypertension screening and treatment among healthcare workers
  2. Assess the short- and long-term effects of a clinical intervention (i.e., patient-level intervention) on patient blood pressure control among patients living with HIV and hypertension

Duration of participation: 27 months Study duration: 37 months

Intervention audience:

  1. Healthcare workers (nurses and doctors)
  2. Adult patients living with HIV from the 9 primary healthcare clinics

Study Type

Interventional

Enrollment (Anticipated)

2160

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gauteng
      • Johannesburg, Gauteng, South Africa, 2193

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Healthcare workers:

  1. Adult >18 years men and women working in clinical roles at the selected clinics
  2. Provide informed consent (only those participating in the qualitative components)

Patients:

  1. Adults >18 years living with HIV and hypertension
  2. Enrolled in the study clinic
  3. Willing and able to provide informed consent

Exclusion Criteria:

Patients:

  1. Unable or unwilling to provide informed consent
  2. Planning to relocate or change service providers/clinics

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Standard of care
Other: Intervention
Cluster of clinics receiving the five investigational interventions
  1. The intervention package prioritizes information and quality management with a focus on HTN screening, diagnosis, and treatment. From the point-of-care, flow charts placed in the patient file will ensure that vitals are performed in accordance with national guidelines.
  2. The care coordinator will present data to clinic staff in multi-disciplinary meetings, providing an opportunity for programmatic feedback and discussion.
  3. Patients will be encouraged to complete the vital signs measurements at each clinic visit. They will be provided with their BP readings and given info about what their reading means. They will be issued with pocket sized color coded booklets providing info on the measurement and what to do to control their BP.
  4. Task shifting: A care coordinator will be the champion of the intervention package for the clinic.
  5. All staff will receive apt training on how to use the patient flow chart, info management system and how to respond to abnormal BP values.
Other Names:
  • 2. Case review meetings
  • 3. Patient health education and support
  • 4. Task shifting
  • 5. HCW education and training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Healthcare worker
Time Frame: 24 months
Difference in percentage of patient visits with recorded BP measurement between intervention and control clinics
24 months
Patient
Time Frame: 12 months
Difference in mean systolic BP between the intervention and control conditions
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Healthcare worker implementation
Time Frame: 24 months
% of healthcare workers who implement the iHEART-SA package as intended at month 12 and month 24
24 months
Healthcare worker adoption
Time Frame: 24 months
Participation rate and representativeness of healthcare workers who adopt the BP screening and treatment model
24 months
Healthcare worker maintenance - BP measurement
Time Frame: 12 months
% of patients who had a BP measurement done at every clinic visit
12 months
Healthcare worker satisfaction
Time Frame: 24 months
% of healthcare workers who are satisfied with all components of the intervention
24 months
Healthcare worker costing
Time Frame: 27 months
Costs of each intervention components will be recorded as healthcare worker time, material costs, and healthcare/monitoring equipment
27 months
Patient adoption
Time Frame: 24 months
Participation rate and representativeness of eligible patients who consent to chart review
24 months
Patient satisfaction
Time Frame: 24 months
% of patients who are satisfied with all components of the intervention
24 months
Healthcare worker maintenance - BP management
Time Frame: 12 months
% of patients who had an elevate BP managed at every visit post intervention
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Willem DF Venter, MD, PHD, Ezintsha, University of the Witwatersrand

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

June 1, 2023

Primary Completion (Anticipated)

May 31, 2025

Study Completion (Anticipated)

August 31, 2025

Study Registration Dates

First Submitted

April 12, 2023

First Submitted That Met QC Criteria

May 3, 2023

First Posted (Estimate)

May 5, 2023

Study Record Updates

Last Update Posted (Estimate)

May 5, 2023

Last Update Submitted That Met QC Criteria

May 3, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • iHEART-SA IS

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on 1. Quality and info management system

3
Subscribe